Boston, Massachusetts 02114


Purpose:

The investigators propose to examine both resting state activity and functional activity during rumination and during self-processing to study the relationship between neural correlates of rumination/self-focus and self-processing in major depression and bipolar disorder.


Study summary:

Negative rumination, a specific form of self-focus, characterized by repetitively focusing on one's symptoms of distress, and the possible causes and consequences of these symptoms, is a hallmark of depression. Nearly a decade of research has culminated in evidence that the tendency to engage in negative rumination is highly correlated with depressive symptoms. Rumination also plays a critical role in the etiology and maintenance of depressed states and predicts risk for mania in bipolar disorder. Despite the central role of rumination in major depression and bipolar disorder, there have been few studies to date investigating the functional neuroanatomy of negative rumination, and no studies of positive rumination. The few neuroimaging studies that have utilized measures of the tendency to engage in negative rumination have focused on brain functioning when performing tasks that involve processing emotional or self-referential stimuli, but they have not studied resting state activity or functional activity during negative and positive rumination. We are examining both resting state activity and functional activity during negative and positive rumination and during self-processing to study the relationship between the neural correlates of rumination/self-focus and self-processing in major depression and bipolar disorder.


Criteria:

Inclusion Criteria Healthy Controls: - Right-handed (as determined by the Handedness Inventory; Oldfield, 1971) - Normal or corrected-to normal vision and hearing Exclusion Criteria for Healthy Controls: - Any current or past psychiatric history - Significant medical, psychiatric or neurological illness - Currently taking antidepressants, mood stabilizers, or benzodiazepines - Positive MR screen (e.g., metal implant, claustrophobia, etc) Inclusion Criteria for Patients with Major Depression: - Current diagnosis of MDD - Right-handed (as determined by the Handedness Inventory; Oldfield, 1971) - Normal or corrected-to normal vision and hearing Exclusion Criteria for MDD Patients: - If a history of substance abuse, at least 6 months in remission - Current suicidal ideation or history of suicide attempts - Positive MR screen (e.g., metal implant, claustrophobia, etc) Inclusion Criteria for patients with BPAD: - Current diagnosis of BPAD - Right-handed (as determined by the Handedness Inventory; Oldfield, 1971) - Normal or corrected-to normal vision and hearing Exclusion Criteria for BPAD Patients: - If a history of substance abuse, at least 6 months in remission - Current suicidal ideation or history of suicide attempts - Positive MR screen (e.g., metal implant, claustrophobia, etc)


NCT ID:

NCT02253225


Primary Contact:

Principal Investigator
Sharmin Ghaznavi, M.D., Ph.D.
Massachusetts General Hospital

Jake Dinerman
Phone: 617-726-7591
Email: jdinerman@mgh.harvard.edu


Backup Contact:

N/A


Location Contact:

Boston, Massachusetts 02114
United States

Jake Dinerman
Phone: 617-726-7591
Email: jdinerman@mgh.harvard.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.